Fred Gordin, MD

Chief, Infectious Diseases; Medical Center Epidemiologist,
Veterans Affairs Medical Center, Washington DC
Professor of Medicine, George Washington University

Phone: (202) 745-830l
Fax: (202) 745-8432
Email: Fred.Gordin@med.va.gov

Current HIV/AIDS Educational Activities:

• Training in HIV medicine for George Washington University medical students, housestaff, and Infectious Diseases fellows

Current HIV/AIDS Clinical Activities:

• Attending Physician in VA Medical Center HIV/AIDS clinic, which cares for over 900 HIV-infected veterans. Patients receive comprehensive care, including on-site primary and specialty care form ID, Neurology, GI and dermatolgy physicians; nurses and NPs; social workers, pharmacists and nutritionists.

Current HIV/AIDS Research Activities:

• Community Programs for Clinical Research on AIDS (CPCRA)
  

  PI of NIAID-funded clinical trials unit with 11 sites conducting research in the ACTG and HPTN network
  2007-present

• ESPRIT

  Multi-site consortium of Veterans Affairs Medical Centers participating in NIH-funded trial of Interleukin-2 for persons with HIV
  1999-present Principal Investigator, Washington DC unit
  1999-present Principal Investigator of VA National Trials Coordinating Center

• Tuberculosis Trials Consortium

  CDC-funded multi-site consortium of Veterans Affairs Medical Centers participating in national clinical trials group
  1994-present Overall Project Officer and Principal Investigator for VA group
  1994-present Principal Investigator, Washington DC unit

Dr Gordin is chief of the Infectious Diseases section at the Washington VA Medical Center and Professor of Medicine at George Washington University. Since 1994, he has been the elected group leader of the CPCRA and overseen its expansion into an international consortium. In this capacity, he has been responsible for the day-to-day operations of the CPCRA's multi-site, multi-study network, i.e., its financial management, regulatory compliance, site performance, protocol implementation, and scientific productivity. Dr Gordin was the overall director of the SMART Study and currently leads the NIH-funded START study - evaluating the best time to initiate HIV treatment.

Since the CPCRA's beginning in 1986, Dr Gordin has also been the Principal Investigator for its clinical unit in Washington DC. Over the years, Dr. Gordin has been instrumental in leading the CPCRA in a diverse portfolio of HIV-related tuberculosis. Dr. Gordin was PI for an 8-year, international study of a 2-month regimen of rifampin and pyrazinamide for the prevention of TB. Dr Gordin's recognized abilities in the field of mycobacterial diseases and HIV have been further demonstrated by his role as a consultant at national CDC meetings, developing guidelines for TB prevention and treatment in HIV-infected populations, and he is currently a member of the CDC's Advisory Committee for the Elimination of Tuberculosis.

He has participated, as well, in several U.S. Public Health Service / Infectious Diseases Society of America panels for the development of guidelines for the prevention of opportunistic infections, giving input in both the areas of TB and of M. avium. His expertise is not limited to the arena of HIV-related opportunistic infections. He has, for example, served on several other committees, setting standards and guidelines for HIV patient care, including antiretroviral therapies. Dr Gordin has served on the FDA Antiviral Drug Advisory Committee for a 4-year term, as well as on the NIAID National Advisory Council for 9 years and the NIH Office of AIDS Research Advisory Council for 2 years. He currently serves on the U.S. Public Health Service treatment guidelines panel, which sets standards for antiretroviral treatment of HIV-infected persons in the United States. Among his publications is the chapter on M. avium Complex, included in the 2005 edition of the Mandell reference, Principles and Practices of Infectious Diseases.